Demographic Data |
Relation to Proband |
proband |
Age at Sampling |
4 YR |
Sex |
Female |
Age at Diagnosis(If not a control) |
20 MO |
Racial Category |
White |
Country |
USA |
|
Data Elements |
Clinical Element Type: General NIGMS Catalog Remarks |
(Baseline) |
Mutation Information |
Gene, variant, consequence, and exon number: |
WHOLE EXOME SEQUENCING REVEALED A DE NOVO AUTOSOMAL DOMINANT MUTATION IN EXON 3 OF THE CHAMP1 GENE: C.1850DUPA (P.LYS618GLUFSX13) |
Zygosity: |
Heterozygous |
Age of Symptom Onset and Age at Diagnosis |
Age of Symptom Onset: |
BIRTH |
Age at Diagnosis: |
20 MONTHS |
In Utero History Information |
|
|
Birth History Information |
|
|
Dysmorphic Features |
|
Abnormal hands or feet Microcephaly
|
Additional Information: |
DYSMORPHIC FEATURES, PLAGIOCEPHALY, HYPOPLASTIC THUMBS, HYPOPLASTIC FINGERNAILS, DISTAL TOES, MACULAR HYPOPLASIA |
Neurological Symptoms |
|
|
Additional Information: |
APNEA FOR GREATER THAN 15 SECONDS |
Optical and Audiological Symptoms |
|
Defective vision
|
Additional Information: |
ACQUIRED NASOLACRIMAL DUCT STENOSIS |
Musculoskeletal Symptoms |
|
|
Developmental Milestones |
|
Global developmental delay
|
Additional Information: |
CHAMP1-RELATED.0 INTELLECTUAL DISABILITY SYNDROME |
Gastrointestinal Symptoms |
|
Constipation
|
Additional Information: |
LACTOSE INTOLERANCE |
Genitourinary Symptoms |
|
|
Respiratory and Cardiovascular Symptoms |
|
|
Cognitive and Behavioral Symptoms |
|
|
Additional Information: |
H/O SELF-HARM |
Additional Information |
Testing Performed |
Treatments and Assistive Devices |
|
Occupational therapy Physical therapy Speech therapy Orthotics
|
Additional Testing: |
COURTNEY BED |
Medications |
|
CALCIUM CARB-CHOLECALCIFEROL, CHOLECALCIFEROL (VITAMIN D3), ASCORBIC ACID (VITAMIN C), POLYETHYLENE GLYCOL (MIRALAX), ONDANSETRON (ZOFRAN), MELATONIN, MULTIVITAMINS AND MINERALS, PROBIOTIC, DHA |
Family History |
|
SEGREGATION ANALYSIS BY WHOLE EXOME SEQUENCING DID NOT REVEAL THE VARIANT IN EITHER PARENT. |